BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712
26 results:

  • 1. In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic cancer Surgery.
    Cano Garcia C; Tappero S; Piccinelli ML; Barletta F; Incesu RB; Morra S; Scheipner L; Baudo A; Tian Z; Hoeh B; Chierigo F; Sorce G; Saad F; Shariat SF; Carmignani L; Ahyai S; Longo N; Tilki D; Briganti A; De Cobell O; Dell'Oglio P; Mandel P; Terrone C; Chun FKH; Karakiewicz PI
    Ann Surg Oncol; 2023 Dec; 30(13):8770-8779. PubMed ID: 37721691
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Stereoselective synthesis of oxime containing Pd(II) compounds: highly effective, selective and stereo-regulated cytotoxicity against carcinogenic PC-3 cells.
    de la Cueva-Alique I; de la Torre-Rubio E; Muñoz-Moreno L; Calvo-Jareño A; Pérez-Redondo A; Gude L; Cuenca T; Royo E
    Dalton Trans; 2022 Aug; 51(34):12812-12828. PubMed ID: 35796301
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy.
    Hoeh B; Flammia RS; Hohenhorst L; Sorce G; Panunzio A; Chierigo F; Nimer N; Tian Z; Saad F; Gallucci M; Briganti A; Shariat SF; Graefen M; Tilki D; Antonelli A; Terrone C; Kluth LA; Becker A; Chun FKH; Karakiewicz PI
    Surg Oncol; 2022 Jun; 42():101783. PubMed ID: 35605557
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center.
    Oderda M; Soria F; Rosi F; Calleris G; Mazzoli S; Giordano A; Pizzuto G; Marquis A; De Bellis M; Vitiello F; Vercelli E; Peretti F; Montefusco G; Gontero P
    World J Urol; 2022 Jan; 40(1):263-269. PubMed ID: 34562122
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomy.
    Wenzel M; Kleimaker A; Uhlig A; Würnschimmel C; Becker A; Yu H; Meyer CP; Fisch M; Chun FKH; Leitsmann M
    Scand J Urol; 2021 Oct; 55(5):377-382. PubMed ID: 34427540
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy.
    Wenzel M; Yu H; Uhlig A; Würnschimmel C; Wallbach M; Becker A; Fisch M; Chun FKH; Meyer CP; Leitsmann M
    Int Urol Nephrol; 2021 Oct; 53(10):2041-2049. PubMed ID: 34269968
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients.
    Würnschimmel C; Collà Ruvolo C; Nocera L; Wenzel M; Tian Z; Saad F; Briganti A; Shariat SF; Mirone V; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
    Eur Urol Focus; 2022 Jan; 8(1):191-199. PubMed ID: 33610487
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Down regulation of u2af1 promotes ARV7 splicing and prostate cancer progression.
    Cao H; Wang D; Gao R; Chen L; Feng Y
    Biochem Biophys Res Commun; 2021 Feb; 541():56-62. PubMed ID: 33477033
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A deep learning framework for prostate localization in cone beam CT-guided radiotherapy.
    Liang X; Zhao W; Hristov DH; Buyyounouski MK; Hancock SL; Bagshaw H; Zhang Q; Xie Y; Xing L
    Med Phys; 2020 Sep; 47(9):4233-4240. PubMed ID: 32583418
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Water soluble, optically active monofunctional Pd(ii) and Pt(ii) compounds: promising adhesive and antimigratory effects on human prostate PC-3 cancer cells.
    de la Cueva-Alique I; Muñoz-Moreno L; de la Torre-Rubio E; Bajo AM; Gude L; Cuenca T; Royo E
    Dalton Trans; 2019 Oct; 48(38):14279-14293. PubMed ID: 31482936
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma.
    González J; Gaynor JJ; Martínez-Salamanca JI; Capitanio U; Tilki D; Carballido JA; Chantada V; Daneshmand S; Evans CP; Gasch C; Gontero P; Haferkamp A; Huang WC; Espinós EL; Master VA; McKiernan JM; Montorsi F; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Hohenfellner M; Libertino JA; Ciancio G
    Eur J Surg Oncol; 2019 Oct; 45(10):1983-1992. PubMed ID: 31155470
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Effect of Institution Teaching Status on Perioperative Outcomes After Robotic Partial or Radical Nephrectomy.
    Marchioni M; Nazzani S; Preisser F; Bandini M; Tian Z; Kapoor A; Cindolo L; Primiceri G; Carmignani L; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
    J Endourol; 2018 Jul; 32(7):621-629. PubMed ID: 29739253
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015.
    Williams VL; Awasthi S; Fink AK; Pow-Sang JM; Park JY; Gerke T; Yamoah K
    Cancer Med; 2018 May; 7(5):2160-2171. PubMed ID: 29601662
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
    Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of perioperative blood transfusion on mortality for major urologic malignancies.
    Soubra A; Zabell JR; Adejoro O; Konety BR
    Clin Genitourin Cancer; 2015 Jun; 13(3):e173-81. PubMed ID: 25600760
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations.
    Lavallée VP; Gendron P; Lemieux S; D'Angelo G; Hébert J; Sauvageau G
    Blood; 2015 Jan; 125(1):140-3. PubMed ID: 25331116
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Preservation surgery in patients with localized renal cell cancer--nephron sparing surgery.
    Djozić J; Djozić S; Bogdanović J; Sekulić V; Djozić M; Vojinov S; Levakov I; Zivojinov S; Jeremić D; Marušić G; Djozić D
    Acta Chir Iugosl; 2014; 61(1):45-9. PubMed ID: 25782225
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Neglected side effects after radical prostatectomy: a systematic review.
    Frey AU; Sønksen J; Fode M
    J Sex Med; 2014 Feb; 11(2):374-85. PubMed ID: 24267516
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.